DBL IRINOTECAN INJECTION CONCENTRATE (irinotecan hydrochloride injection) Patient information

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

DBL IRINOTECAN INJECTION CONCENTRATE Quick Finder

Need to report an Adverse Event, Side Effect, or Product Quality Concern?

You may report an adverse event via email at: [email protected]. For concerns about the quality of a Pfizer product please call 1800 675 229.
Resources

Did you find an answer to your question? Yes No

Didn’t find what you were looking for? Contact us.

Call 1 800 675 229^*

^*9AM-5PM (AEST) Monday to Friday

Connect with Pfizer Medical Information regarding your medical question.

Medical Enquiry

Submit a medical question for Pfizer prescription products.

Pfizer Safety

Contact Pfizer Safety via email at [email protected] to report a suspected side effect or adverse reaction.

For concerns about the quality of a Pfizer product please call 1800 675 229.